Veradigm | MDRX - Market Capitalization


Veradigm reported $466.1M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcidion AUD 141.01M 6.71M Dec/2025
Ambu A/S DKK 3.14B 21.8B Dec/2025
Cardinal Health USD 48.83B 11.54B Dec/2025
Centene USD 20.23B 2.7B Dec/2025
Charles River Laboratories USD 10.02B 2.71B Dec/2025
Cigna USD 73.52B 3.42B Dec/2025
Coloplast 124.69B 775.88M Dec/2025
CVS Health USD 100.74B 5.12B Dec/2025
Diasorin EUR 3.84B 386.04M Dec/2025
Elevance Health USD 76.12B 11.81B Apr/2026
General Electric Aerospace USD 310.34B 13.85B Apr/2026
Gulf Medical Proj AED 1.36B 167.74M Dec/2025
Humana USD 30.81B 485M Dec/2025
IQVIA Holdings USD 29.18B 9.2B Apr/2026
Laboratory Of America USD 20.8B 3.03B Dec/2025
Maximus USD 4.7B 307M Dec/2025
McKesson USD 101.25B 5.15B Dec/2025
Med Life RON 4.16B 601.5M Sep/2025
Molina Healthcare USD 8.95B 2B Apr/2026
Omnicell USD 2.03B 634M Dec/2025
Oriola-kd EUR 213.12M 0 Dec/2025
Owens Minor USD 217M 154M Dec/2025
Quest Diagnostics USD 22.89B 1.19B Apr/2026
Rede D'or Sao Luiz BRL 92.97B 3.37B Dec/2025
Siemens Healthineers EUR 50.67B 1.24B Dec/2025
Supermax Corporation Bhd MYR 1.09B 375.44M Dec/2025
UnitedHealth USD 319B 73.39B Apr/2026
Veeva Systems USD 33.52B 14.21B Dec/2025
Veradigm USD 525M 621M Mar/2026